Personalised Medicine: Dose By Design

Episodes

First
Broadcast
RepeatedComments
20160816

20160816

Personalised medicine means the right treatment for the right person at the right time. It's a revolution in healthcare that's apparently been heading to our local surgery ever since the first human genome sequence was announced in 2000. Our individual genetic barcodes, we've been told, will inform our personal medical care through our lifetimes. The one-size-fits-all medical model is dead, long live precision medicine.

But although genetic medicine and personalised care is happening in startling ways up and down the country (from cancer to HIV treatment to inherited diabetes) wholesale adoption of genomics to prevent, diagnose and treat disease, has some way to go.

Vivienne Parry, life long genetics enthusiast, now helping to deliver the 100,000 Genomes Project, investigates whether the NHS, at a time of huge financial uncertainty, can be nimble enough, decisive enough and forward-thinking enough, to overcome institutional inertia and adapt and deliver the benefits of genomic medicine for all.

Producer: Fiona Hill.

2016081620160821 (R4)

Vivienne Parry asks if the NHS can deliver the benefits of genomic medicine for all.

Personalised medicine means the right treatment for the right person at the right time. It's a revolution in healthcare that's apparently been heading to our local surgery ever since the first human genome sequence was announced in 2000. Our individual genetic barcodes, we've been told, will inform our personal medical care through our lifetimes. The one-size-fits-all medical model is dead, long live precision medicine.

But although genetic medicine and personalised care is happening in startling ways up and down the country (from cancer to HIV treatment to inherited diabetes) wholesale adoption of genomics to prevent, diagnose and treat disease, has some way to go.

Vivienne Parry, life long genetics enthusiast, now helping to deliver the 100,000 Genomes Project, investigates whether the NHS, at a time of huge financial uncertainty, can be nimble enough, decisive enough and forward-thinking enough, to overcome institutional inertia and adapt and deliver the benefits of genomic medicine for all.

Producer: Fiona Hill.